BR112017009605A2 - método para o diagnóstico da doença de niemann-pick usando um biomarcador - Google Patents

método para o diagnóstico da doença de niemann-pick usando um biomarcador

Info

Publication number
BR112017009605A2
BR112017009605A2 BR112017009605A BR112017009605A BR112017009605A2 BR 112017009605 A2 BR112017009605 A2 BR 112017009605A2 BR 112017009605 A BR112017009605 A BR 112017009605A BR 112017009605 A BR112017009605 A BR 112017009605A BR 112017009605 A2 BR112017009605 A2 BR 112017009605A2
Authority
BR
Brazil
Prior art keywords
biomarker
pick disease
diagnosing niemann
niemann
diagnosing
Prior art date
Application number
BR112017009605A
Other languages
English (en)
Portuguese (pt)
Inventor
Rolfs Arndt
Mascher Hermann
Original Assignee
Centogene Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Centogene Ag filed Critical Centogene Ag
Publication of BR112017009605A2 publication Critical patent/BR112017009605A2/pt

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/92Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving lipids, e.g. cholesterol, lipoproteins, or their receptors
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/156Polymorphic or mutational markers
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2405/00Assays, e.g. immunoassays or enzyme assays, involving lipids
    • G01N2405/08Sphingolipids
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2560/00Chemical aspects of mass spectrometric analysis of biological material
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00Detection or diagnosis of diseases
    • G01N2800/04Endocrine or metabolic disorders
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00Detection or diagnosis of diseases
    • G01N2800/50Determining the risk of developing a disease
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00Detection or diagnosis of diseases
    • G01N2800/52Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Analytical Chemistry (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Biophysics (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • General Physics & Mathematics (AREA)
  • Medicinal Chemistry (AREA)
  • Endocrinology (AREA)
  • Food Science & Technology (AREA)
  • Cell Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Other Investigation Or Analysis Of Materials By Electrical Means (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
BR112017009605A 2014-11-19 2015-11-19 método para o diagnóstico da doença de niemann-pick usando um biomarcador BR112017009605A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP14003888 2014-11-19
PCT/EP2015/002313 WO2016078762A1 (en) 2014-11-19 2015-11-19 Method for the diagnosis of niemann-pick disease using a biomarker

Publications (1)

Publication Number Publication Date
BR112017009605A2 true BR112017009605A2 (pt) 2017-12-19

Family

ID=51945677

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112017009605A BR112017009605A2 (pt) 2014-11-19 2015-11-19 método para o diagnóstico da doença de niemann-pick usando um biomarcador

Country Status (8)

Country Link
US (1) US20180348239A1 (https=)
EP (1) EP3221705A1 (https=)
JP (1) JP2017538927A (https=)
AU (1) AU2015349030A1 (https=)
BR (1) BR112017009605A2 (https=)
CA (1) CA2967504A1 (https=)
IL (1) IL251879A0 (https=)
WO (1) WO2016078762A1 (https=)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2021036201A (ja) * 2017-12-18 2021-03-04 国立研究開発法人国立成育医療研究センター ニーマンピック病c型の診断のための検査方法
EP3894864A2 (en) * 2018-12-10 2021-10-20 Denali Therapeutics Inc. Lysosomal storage disorder biomarkers and methods of use thereof

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8497122B2 (en) * 2008-04-11 2013-07-30 Washington University Biomarkers for Niemann-pick C disease and related disorders
CA2854668A1 (en) * 2011-11-15 2013-05-23 Centogene Ag Method for the diagnosis of niemann-pick disease
ES2731920T3 (es) * 2013-05-14 2019-11-19 Centogene Ag Método para el diagnóstico de la enfermedad de Niemann-Pick

Also Published As

Publication number Publication date
WO2016078762A1 (en) 2016-05-26
AU2015349030A1 (en) 2017-05-04
EP3221705A1 (en) 2017-09-27
US20180348239A1 (en) 2018-12-06
CA2967504A1 (en) 2016-05-26
JP2017538927A (ja) 2017-12-28
IL251879A0 (en) 2017-06-29

Similar Documents

Publication Publication Date Title
MX2017016647A (es) Anticuerpos y fragmentos anti-vista.
DK3067817T3 (da) Dynamisk data-maskering til mainframe-applikation
BR112017001677A2 (pt) biomarcadores para predizer resposta de dlbcl ao tratamento com um inibidor de btk
EA201590027A1 (ru) Способы детекции заболеваний или состояний
MX2016001719A (es) Metodos y equipos para predecir el riesgo de tener una enfermedad o evento cardiovascular.
BR112016025627A2 (pt) biomarcadores e combinações dos mesmos para diagnóstico de tuberculose
FI20155280L (fi) Aivovamman prognostisia ja diagnostisia glykaanipohjaisia biomarkkereita
BR112016024494A2 (pt) análogos de peptídeo com sonda(s) de aminoácidos ramificados
MX2017005888A (es) Dispositivos, sistemas y metodos para la deteccion de analitos.
EP3218683C0 (de) Bremsenprüfstand
IL253710B (en) Biomarkers for pancreatic cancer and kits and methods for detecting same
UY36223A (es) Dispositivos para ensayos, métodos para realizar ensayos, kits para ensayos y método para fabricar dispositivos para ensayos
EP3459140A4 (en) FREE SPACE SEGMENT TESTER (FSST)
EP3014505A4 (en) Pathway analysis for identification of diagnostic tests
EA201591742A1 (ru) Способ улучшения диагностики заболеваний с использованием измеряемых аналитов
EP3539027A4 (en) RECONSTRUCTION BASED ON WAVEFORMS AND ALLOWING EMULATION
DK3092493T3 (da) Fremgangsmåder til at diagnosticere eller monitorere muskeldystrofier
MX2017000840A (es) Metodo para predecir el resultado de un tratamiento con aflibercept de un paciente que se sospecha que padece un cancer.
BR112017004299A2 (pt) dispositivo e método de processamento de informação, e, programa.
MX383423B (es) Método in vitro para el diagnóstico del síndrqme del intestino irritable y la enfermedad inflamatoria intestinal.
BR112013030122A2 (pt) método para simular uma resposta de um instrumento de perfilagem de poço de nêutrons, meio legível por computador não transitório, e método para perfilagem de poço
DK3512747T3 (da) Driftsfremgangsmåde til et udrykningskøretøj
BR112017006593A2 (pt) método para detectar câncer de ovário
BR112014009223A2 (pt) método para o diagnóstico da doença de niemann-pick
EP3519337A4 (en) METHOD FOR MAINTAINING AN ELEVATOR COMPONENT

Legal Events

Date Code Title Description
B25G Requested change of headquarter approved

Owner name: CENTOGENE AG (DE)

B06U Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette]
B25D Requested change of name of applicant approved

Owner name: CENTOGENE GMBH (DE)

B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 6A ANUIDADE.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 DA RPI 2645 DE 14/09/2021.